Mary L. (Nora) Disis, MD June 13th 2023 Mary “Nora” Disis, MD, discusses the results of a phase 1/1b study of PRGN-3005 autologous UltraCAR T cells in patients with advanced stage platinum-resistant ovarian cancer. Read More
Mary L. (Nora) Disis, MD: Ready to become editor in chief of the new JAMA Oncology.HamptonTracy(AUTHOR)EBSCO_AspJama Journal of the American Medical Association